News And Press

Delta and Omicron Variants are Driving New Cases


During the COVID-19 pandemic, new cases in the U.S. have repeatedly risen and dropped dramatically.

More Evidence for T-Cells: Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts


A new research paper led by the Imperial College London, published in the peer-reviewed journal nature communications, finds the following:.

The Peer Reviewed Journal Vaccines Published the Results of Flow Pharma’s COVID-19 Primate Study

Company Update, COVID-19, FLOVID-20

Flow Pharma, Inc., a San Francisco Bay Area biotechnology company developing the FlowVax™ peptide vaccine platform technology, today announced the publication of an article describing research performed at the University of Texas Medical Branch at Galveston (UTMB)

Natural variants in SARS-CoV-2 Spike protein pinpoint structural and functional hotspots with implications for prophylaxis and therapeutic strategies

Research Publications

In December 2019, a novel coronavirus, termed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified as the cause of pneumonia with severe respiratory distress and outbreaks in Wuhan, China.